Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK


Primary Symbol: TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.


NYSE:TAK - Post by User

Comment by Bedilgenton Sep 01, 2013 9:11pm
333 Views
Post# 21712703

RE:RE:Krutec TAK management and exploration team

RE:RE:Krutec TAK management and exploration teamI agree. The ex-union boys got very well paid for splitting the original Hinterland into two companies which included Stakeholder Gold. My understanding is that was the ex-union guys idea and he sucked a whole pile of fees out for that exercise. The ex-union guys had a falling out with Hinterland and Stakeholders pres Mark Fekete when he decided to do a non-brokered private placement instead of a brokered private placement with the boys a few summers back. Everything went for a doo-doo and the shareholders were left holding the bag. EXS, HMI, TK SRC, AOK and now TK. Good luck with that track record as it is nothinh but bodies on the side of the road. We will see if there is a trade in Tinka in the coming weeks after the pullback from the $1.20 level where it was overvalued.
Bullboard Posts